University of California, San Diego, Department of Neurosciences, La Jolla, CA, USA.
Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA.
J Alzheimers Dis. 2019;72(2):575-585. doi: 10.3233/JAD-190656.
Extracellular vesicles (EVs) are a heterogeneous group of secreted particles consisting of microvesicles, which are released by budding of the cellular membrane, and exosomes, which are secreted through exocytosis from multivesicular bodies. EV cargo consists of a wide range of proteins and nucleic acids that can be transferred between cells. Importantly, EVs may be pathogenically involved in neurodegenerative diseases such as Alzheimer's disease (AD). While EVs derived from AD neurons have been found to be neurotoxic in vitro, little is known about the pathological consequences of AD EVs in vivo. Furthermore, although all known familial AD (fAD) mutations involve either amyloid-β protein precursor (AβPP) or the machinery that processes AβPP, hyperphosphorylation of the microtubule associated protein tau appears to play a critical role in fAD-associated neurodegeneration, and previous reports suggest EVs may propagate tau pathology in the AD brain. Therefore, we hypothesized that fAD EVs may have a mechanistic involvement in the development of fAD-associated tau pathology. To test this, we isolated EVs from iPSC-derived neuronal cultures generated from an fAD patient harboring a A246E mutation to presenilin-1 and stereotactically injected these EVs into the hippocampi of wild-type C57BL/6 mice. Five weeks after injection, mice were euthanized and pathology evaluated. Mice injected with fAD EVs displayed increased tau phosphorylation at multiple sites relative to PBS and non-disease control EV injected groups. Moreover, fAD EV injected hippocampi contained significantly more tau inclusions in the CA1 hippocampal neuronal field than controls. In total, these findings identify EVs as a potential mediator of fAD-associated tau dysregulation and warrant future studies to investigate the therapeutic potential of EV-targeted treatments for fAD.
细胞外囊泡(EVs)是一组异质性的分泌颗粒,由微泡组成,通过细胞膜出芽释放,由多泡体通过胞吐作用分泌的外泌体组成。EV 货物包含广泛的蛋白质和核酸,可以在细胞之间转移。重要的是,EVs 可能与神经退行性疾病如阿尔茨海默病(AD)有关。虽然已经发现 AD 神经元衍生的 EV 在体外具有神经毒性,但对 AD EV 在体内的病理后果知之甚少。此外,尽管所有已知的家族性 AD(fAD)突变都涉及淀粉样蛋白-β前体(AβPP)或加工 AβPP 的机制,但微管相关蛋白 tau 的过度磷酸化似乎在 fAD 相关神经退行性变中发挥关键作用,并且之前的报告表明 EVs 可能在 AD 大脑中传播 tau 病理学。因此,我们假设 fAD EVs 可能在 fAD 相关 tau 病理学的发展中具有机制上的参与。为了验证这一点,我们从携带 A246E 突变到早老素-1的 iPSC 衍生神经元培养物中分离出 EVs,并立体定向地将这些 EVs注射到野生型 C57BL/6 小鼠的海马体中。注射后 5 周,处死小鼠并评估病理学。与 PBS 和非疾病对照 EV 注射组相比,注射 fAD EV 的小鼠显示出多个部位 tau 磷酸化增加。此外,fAD EV 注射的海马体中 CA1 海马神经元区的 tau 包含体明显多于对照。总之,这些发现表明 EVs 是 fAD 相关 tau 失调的潜在介质,并需要进一步研究来探讨针对 fAD 的 EV 靶向治疗的治疗潜力。